Physician profile
Guy Talmor
NPI 1033679766
$3,587.06
in general payments reported to CMS, 2019-2025
8 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,561 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,178 · Food and Beverage: $1,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,178.43 |
| Food and Beverage | $1,408.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,047.17 | 2024-2025 | |
| Inspire Medical Systems, INC. | $1,236.49 | 2024-2025 | Inspire |
| Genzyme Corporation | $115.21 | 2024-2025 | |
| Optinose US, INC. | $63.77 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $50.70 | 2025 | Dupixent |
| Medtronic, INC. | $36.36 | 2024 | Propel |
| Ars Pharmaceuticals Operations, INC. | $23.34 | 2025 | Neffy |
| Phathom Pharmaceuticals, INC. | $14.02 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Talmor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.